Literature DB >> 31472916

Role of Radioembolization for Biliary Tract and Primary Liver Cancer.

Amy C Taylor1, Dilip Maddirela2, Sarah B White3.   

Abstract

Hepatocellular carcinoma and intrahepatic cholangiocarcinoma are often amenable to locoregional therapy, including percutaneous ablation, transarterial chemoembolization (TACE), or transarterial radioembolization (TARE). TARE is a technique that delivers a high dose of radiation to the tumor, while limiting the dose to the normal liver parenchyma and the adjacent organs. It has been shown to effectively provide disease control with relatively few toxicities, and in certain cases results in a complete response. It is the preferred therapy as a bridge to liver transplant and can provide necessary compensatory future liver remnant hypertrophy before planned surgical resection.
Copyright © 2019 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  (90)Y; Cholangiocarcinoma; Hepatocellular carcinoma; Radiation lobectomy; Radiation segmentectomy; Selective internal radiotherapy (SIRT); Transarterial radioembolization

Mesh:

Year:  2019        PMID: 31472916     DOI: 10.1016/j.soc.2019.07.001

Source DB:  PubMed          Journal:  Surg Oncol Clin N Am        ISSN: 1055-3207            Impact factor:   3.495


  3 in total

1.  Liver Transplantation for Unresectable Intrahepatic Cholangiocarcinoma: The Role of Sequencing Genetic Profiling.

Authors:  Salvatore Gruttadauria; Floriana Barbera; Duilio Pagano; Rosa Liotta; Roberto Miraglia; Marco Barbara; Maria Grazia Bavetta; Calogero Cammà; Ioannis Petridis; Daniele Di Carlo; Pier Giulio Conaldi; Fabrizio Di Francesco
Journal:  Cancers (Basel)       Date:  2021-12-01       Impact factor: 6.639

2.  Current Trends in Inpatient Care and In-Hospital Mortality of Cholangiocarcinoma in Germany: A Systematic Analysis between 2010 and 2019.

Authors:  Christoph Roderburg; Tobias Essing; Linde Kehmann; Sarah Krieg; Simon Labuhn; Jennis Kandler; Tom Luedde; Sven H Loosen
Journal:  Cancers (Basel)       Date:  2022-08-21       Impact factor: 6.575

Review 3.  SIRT in 2025.

Authors:  Francesca Romana Ponziani; Francesco Santopaolo; Antonio Gasbarrini; Roberto Iezzi; Alessandro Posa; Maurizio Pompili; Alessandro Tanzilli; Marta Maestri; Maria Pallozzi; Francesca Ibba; Riccardo Manfredi
Journal:  Cardiovasc Intervent Radiol       Date:  2022-08-08       Impact factor: 2.797

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.